Diabetes Care Drugs & Devices Market is expected to reach US$ 244.46 billion by 2033 | Abbott Laboratories, Medtronic plc, Terumo Corporation, B. Braun SE, Merck & Co., Inc., Novo Nordisk

Diabetes Care Drugs & Devices Market reached US$ 119.86 billion in 2024 and is expected to reach US$ 244.46 billion by 2033, growing at a CAGR of 8.3% during the forecast period 2025-2033.

The Diabetes Care Drugs & Devices Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/diabetes-care-drugs-and-devices-market?sg

Diabetes Care Drugs & Devices Market Landscape Analysis:

Diabetes care drugs and devices encompass a broad range of pharmaceutical therapies and medical technologies designed to manage and control diabetes-a chronic condition marked by elevated blood sugar levels. These products are essential in preventing long-term complications such as cardiovascular disease, nerve damage, kidney failure, and vision impairment, which are commonly associated with poorly managed diabetes.

Medications used in diabetes care work by regulating blood glucose levels through various mechanisms, such as stimulating insulin secretion, enhancing insulin sensitivity, or slowing glucose absorption. These drugs are classified into multiple categories based on their mode of action and are tailored to meet the individual needs of patients with Type 1 or Type 2 diabetes.

On the technological side, diabetes care devices play a critical role in monitoring and treatment delivery. This includes tools like blood glucose meters, continuous glucose monitoring (CGM) systems, insulin pumps, and smart insulin pens, all designed to improve the accuracy, efficiency, and convenience of diabetes management. The integration of digital health platforms and wearable technologies has significantly enhanced patient engagement and adherence to treatment plans.

The global diabetes care drugs and devices market is witnessing robust growth due to the rising prevalence of diabetes and continuous innovation in treatment and monitoring solutions. A key example is the September 2024 FDA approval of the Eversense 365 CGM system, developed by Senseonics Holdings, Inc. in collaboration with Ascensia Diabetes Care. This system, the first CGM with a one-year sensor lifespan, marks a major advancement in long-term glucose monitoring for adults with both Type 1 and Type 2 diabetes, highlighting the ongoing evolution of diabetes care technology.

Diabetes Care Drugs & Devices Market: Shifting Industry Trends and Market Potential

Rising Prevalence of Diabetes Driving Demand for Care Solutions

The growing global burden of diabetes is a major force behind the expansion of the diabetes care drugs and devices market. Factors such as sedentary lifestyles, poor dietary habits, increasing obesity rates, and aging populations are contributing to a sharp rise in diabetes cases worldwide. As the number of individuals affected by this chronic condition climbs, so does the need for effective monitoring tools and therapeutic interventions.

According to the International Diabetes Federation (IDF), an estimated 536.6 million adults aged 20 to 79 were living with diabetes in 2021 approximately 1 in every 10 people. This figure is projected to rise to 642.8 million by 2030 and exceed 783.7 million by 2045. Notably, over 75% of people with diabetes reside in low- and middle-income countries, underscoring a critical global healthcare challenge.

As diabetes progresses, patients require continuous monitoring and long-term medication management to keep blood glucose levels in check. This has led to increased demand for self-monitoring blood glucose (SMBG) systems, continuous glucose monitors (CGMs), insulin pumps, insulin pens, and a variety of pharmacological therapies, including insulin and oral antidiabetic drugs.

In response to this growing demand, manufacturers are focusing on innovation to deliver more efficient and user-friendly products. A recent example is Insulet Corporation's announcement in August 2024 regarding the expanded indication of its Omnipod 5 Automated Insulin Delivery System. Now FDA-cleared for use by adults with Type 2 diabetes (ages 18 and older), Omnipod 5 is the first and only AID system approved for managing both Type 1 and Type 2 diabetes in the United States. This development reflects the industry's ongoing efforts to broaden access to advanced diabetes management technologies across a wider patient population.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/diabetes-care-drugs-and-devices-market?sg

Strategic Players Driving the Diabetes Care Drugs & Devices Market Forward: F. Hoffmann-La Roche Ltd, Abbott Laboratories, Medtronic plc, Terumo Corporation, B. Braun SE, Merck & Co., Inc., Novo Nordisk A/S., Eli Lilly and Company, Boehringer Ingelheim Pharmaceuticals, Inc., Insulet Corporation.

Research Methodology:

The global Diabetes Care Drugs & Devices Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Segment Covered in the Diabetes Care Drugs & Devices Market:

By Product Type (Diabetes Devices and Diabetes Drugs)

By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes and Prediabetes)

By End-User (Hospitals, Specialty Clinics, Homecare Settings, Diagnostic Centers and Others)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Regional Analysis for Diabetes Care Drugs & Devices Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Diabetes Care Drugs & Devices Market Research Industry:

➠ Who leads the Diabetes Care Drugs & Devices industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Diabetes Care Drugs & Devices market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Diabetes Care Drugs & Devices market growth?

➠ What are the dominant sales and distribution strategies in the Diabetes Care Drugs & Devices industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.